Related Experiment Video
Updated: Jun 16, 2026

Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease Genes
Published on: July 18, 2008
Global microRNA expression profiling of Caenorhabditis elegans Parkinson's disease models
Suvi Asikainen1, Martina Rudgalvyte, Liisa Heikkinen
1Department of Biosciences, Kuopio University, Kuopio, Finland.
Abstract:
MicroRNAs (miRNAs) play an important role in human brain development and maintenance. To search for miRNAs that may be involved in the pathogenesis of Parkinsons disease (PD), we utilized miRNA microarrays to identify potential gene expression changes in 115 annotated miRNAs in PD-associated Caenorhabditis elegans models that either overexpress human A53T alpha-synuclein or have mutations within the vesicular catecholamine transporter (cat-1) or parkin (pdr-1) ortholog. Here, we show that 12 specific miRNAs are differentially regulated in the animals overexpressing alpha-synuclein, five in cat-1, and three in the pdr-1 mutants. The family of miR-64 and miR-65 are co-underexpressed in the alpha-synuclein transgenic and cat-1 strains, and members of let-7 family co-underexpressed in the alpha-synuclein and pdr-1 strains; mdl-1 and ptc-1 genes are target candidates for miR-64 and miR-65 and are overexpressed in alpha-synuclein transgenic as well as miR-64/65 (tm3711) knockout animals. These results indicate that miRNAs are differentially expressed in C. elegans PD models and suggest a role for these molecules in disease pathogenesis.
Insights
MicroRNAs (miRNAs) are differentially expressed in Parkinson's disease (PD) models in C. elegans. These findings suggest miRNAs play a role in PD pathogenesis.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- MicroRNAs (miRNAs) are crucial for human brain development and maintenance.
- Parkinson's disease (PD) pathogenesis involves complex genetic and molecular mechanisms.
- Understanding miRNA involvement in PD could reveal novel therapeutic targets.
Purpose of the Study:
- To identify specific miRNAs involved in the pathogenesis of Parkinson's disease (PD).
- To investigate miRNA expression changes in C. elegans models of PD.
Main Methods:
- Utilized miRNA microarrays to analyze 115 annotated miRNAs.
- Examined PD models in C. elegans: alpha-synuclein overexpression, cat-1, and pdr-1 mutants.
- Identified differentially regulated miRNAs and potential gene targets.
Main Results:
- 12 miRNAs were differentially regulated in alpha-synuclein overexpressing models.
- 5 miRNAs were altered in cat-1 mutants and 3 in pdr-1 mutants.
- miR-64/65 and let-7 family miRNAs showed co-underexpression patterns; mdl-1 and ptc-1 identified as potential targets.
Conclusions:
- MicroRNAs exhibit differential expression in C. elegans PD models.
- These findings suggest a significant role for miRNAs in the pathogenesis of Parkinson's disease.
- Further research into miRNA function in PD is warranted.
More Related Videos
05:17Assessing Gastrointestinal Motility in Caenorhabditis elegans RAC1/CED-10 Mutants as a Tool to Study Early Parkinson's Disease
Published on: November 28, 2025
06:17Quantifying Levels of Dopaminergic Neuron Morphological Alteration and Degeneration in Caenorhabditis elegans
Published on: November 20, 2021